4
Changes in Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0001193125-26-122341
VP, Finance and Controller sold 390 shares at $8.61 ($3,358)
- VP, Finance and Controller acquired 1,086 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Gupta Ashoo · VP, Finance and Controller
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-20 | Exercise or conversion : show line 1 in the form | +865 | 47,224 | D | ||
| 2026-03-20 | Sale : show line 2 in the form | −310 | $8.61 | $2,669 | 46,914 | D |
| 2026-03-20 | Exercise or conversion : show line 3 in the form | +221 | 47,135 | D | ||
| 2026-03-20 | Sale : show line 4 in the form | −80 | $8.61 | $689 | 47,055 | D |
| Open-market sales · 390 sh · avg $8.61 · $3,358 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-20 | Exercise or conversion : show line 5 in the form Restricted Stock Units | −865 | 12,119 | D |
| 2026-03-20 | Exercise or conversion : show line 6 in the form Restricted Stock Units | −221 | 3,087 | D |
Loading xslF345X06/ownership.xml…